APA

Validire P., Fermé C., Brice P., Diviné M., Gabarre J., Bouabdallah K., Fitoussi O., Chaoui D., Pacquement H., Soussain C., Carde P., Salhi R., Zanni M. & Decaudin D. (20080619). A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. : Anti-cancer drugs.

Chicago

Validire Patricia, Fermé Christophe, Brice Pauline, Diviné Marine, Gabarre Jean, Bouabdallah Krimo, Fitoussi Olivier, Chaoui Driss, Pacquement Hélène, Soussain Carole, Carde Patrice, Salhi Rafika, Zanni Manuela and Decaudin Didier. 20080619. A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. : Anti-cancer drugs.

Harvard

Validire P., Fermé C., Brice P., Diviné M., Gabarre J., Bouabdallah K., Fitoussi O., Chaoui D., Pacquement H., Soussain C., Carde P., Salhi R., Zanni M. and Decaudin D. (20080619). A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. : Anti-cancer drugs.

MLA

Validire Patricia, Fermé Christophe, Brice Pauline, Diviné Marine, Gabarre Jean, Bouabdallah Krimo, Fitoussi Olivier, Chaoui Driss, Pacquement Hélène, Soussain Carole, Carde Patrice, Salhi Rafika, Zanni Manuela and Decaudin Didier. A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. : Anti-cancer drugs. 20080619.